ROARABLE
Today ⌘ Pro Terminal Big Ideas 🎲 Predictions Screener πŸ¦‹ Butterfly 8 Analysts πŸ›οΈ Policy 🎬 Video β˜… Watchlist 🎲 Prediction Markets πŸ“Š RQD Track Record πŸ“… Next Catalysts πŸ›‘οΈ Overlap & Crash X-Ray πŸ“° Live Wire πŸ‹ 13F Whales πŸ›οΈ Congress & CEO Buys πŸ† $100K Arena ⌘ Pro Terminal πŸ“ Methodology & Corrections
Stock Ratings / Technology / DH / insiders
SWMR (26) EGAN (59) HUCK (29) AEYE (46) ⌘ Pro Terminal β†’

Definitive Healthcare Corp. (Class A) (DH) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$1.12 0.00% NASDAQ β€’ Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $1.12

Definitive Healthcare Corp. (Class A) (DH) carries a Roarable Rating of D (Sell) with 48/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

πŸ“Š Historical Track Record Warning: Scores below 50 (48/100 Β· D) historically underperformed SPY in 71% of rolling 90-day windows β†’
ROARABLE D β€’ SELL / AVOID Cap $162.4M
πŸ“€ Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚑ INSTANT AI QUANT PREVIEW β€’ $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on DH Below β€” or Connect Your Own ChatGPT / Claude
πŸ€– Mara Quenwick β€’ AI Quant Lead (Click for Instant Brief) Is DH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
β–Ό

As of 2026-11-02, Definitive Healthcare Corp. (Class A) (NASDAQ: DH) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 48/100 at a spot price of $1.12 (0.00% 1D, market cap $162.4M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 12/20, and SEC Balance-Sheet Forensics 11/20. Across 714 tracked Technology issuers, DH ranks #384 in composite RQD confidence.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Ellis Vennor β€’ AI Peer & Flow Quant (Click for Instant Brief) How does DH compare to SWMR and EGAN in the Technology sector?
β–Ό

Within the Technology sector (Computer Software: Prepackaged Software), DH carries a Roarable D (48/100 RQD), trailing P/E of N/A, gross margin of 75.9%, and ROIC of -35.0%. By comparison, SWMR (Swarmer Inc) holds a E grade (26/100 RQD, P/E N/A, ROIC -35.0%, cap $167.4M) and EGAN (eGain Corporation) posts a C- grade (59/100 RQD, P/E 4.7x, ROIC 46.7%, cap $150.1M). Among the 5-stock peer group, EGAN leads on earnings multiple (4.7x) while EGAN leads on capital efficiency (46.7% ROIC).

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Gideon Ashmere β€’ AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for DH?
β–Ό

Per DH's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001861795), Definitive Healthcare Corp. (Class A) generated $241.5M in revenue (-4.2% YoY), -$138.9M in net income, and $37.1M in free cash flow against $735.5M in total assets and $156.1M in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity.. Primary risk factors monitored: Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.. Institutional options positioning shows a 50% call / 50% put premium split.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists β€” not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
πŸ›‘οΈ Portfolio Crash X-Ray
EXT / AFTER-HRS: $1.12 (-0.19%)🧬 Cannibal Buyback (-0.96% YoY Shares)βš™οΈ Cash Engine: 4/20 (E) β€’ 15.3% FCF Margin
Verify 90D Bucket Audit β†’
πŸ“Š Historical Track Record Warning: Scores below 50 (48/100 Β· D) historically underperformed SPY in 71% of rolling 90-day windows (-5.6% avg 90D alpha vs SPY β€’ 29.0% hit rate).
Audit Bucket Track Record β†’
RQD QUANT TACHOMETERSELL / AVOID β€’ D
025507510048
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) β€” not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- Β· Rk D+
Cash (4)Whales (11)SEC (10)Macro (12)CEO (11)
Each axis scored 0–20
12M PRICE TARGET CONE-4.5% Base Target
$3 Bull$1 Base$1 Bear
πŸ“¬ FREE DH RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: β€” (No Active Options Snapshot on file for DH)Realized 20D OHLCV Swing Band: Β±10.8%
Deterministic 5-Pillar Attribution (48/100 Composite)
πŸ” WHY DH SCORES 48/100 (D) β€” TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
β–² #1 Bullish Driver: Macro Regime Fit+12/20 pts (25% of score)

FRED Regime Γ— Technicals: 21% of 52W Range β€’ RSI-14 at 63.9 (BULLISH MOMENTUM)

β–² #2 Bullish Driver: Whale & Options Positioning+11/20 pts (23% of score)

20D Institutional Volume Accumulation (Β±10.8% realized swing band)

β–Ό #1 Drag / Risk Factor: Cash Engine Quality4/20 pts (-16 pt drag)

Capital intensity & 0% operating margin leave 16 pts on the table

πŸ“ˆ PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 β†’ Q2 β†’ Q3 β†’ Current
Q1 (-3Q)
40
Grade D$0.98+12.2% Next Q
Q2 (-2Q)
43
Grade D$1.10-1.8% Next Q
Q3 (-1Q)
45
Grade D$1.08+3.7% Next Q
Current
48
Grade D$1.12-5.6% Hist 90D Ξ±
Trajectory: D (40) β†’ D (48)Full Audit β†’
βš”οΈ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

βš”οΈ Adversarial Opposing Case: What Could Spark a DH Turnaround Squeeze

Gideon Ashmere Forensic Desk β†’

While DH currently carries a cautious 48/100 (D) rating due to Cash Engine Quality (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

πŸš€ Contrarian Squeeze Trigger #1

Established market leader in Technology with deep daily trading liquidity.

πŸš€ Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($0.99) and Max Pain ($1.18) forces dealer call-delta covering toward $3.15.

πŸš€ Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Cannibal Buyback (-0.96% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $DHβ€’ $4.8M Crowd Pool β€’ Kalshi / Polymarket Composite
Contract: β€œDH Beats Next Quarterly Revenue & EPS Consensus + Hyperscaler AI CapEx Holds Record Pace”
YES 48%NO 52%Trade / Inspect Odds β†’
SEC FORM 4 Γ— 13F HEDGE FUNDS Γ— CONGRESSIONAL STOCK ACT

DH Smart-Money Thermometer: BALANCED INSTITUTIONAL POSITIONING

Explore All 13F & Congress Whales β†’
β–² Disclosed Buys: 0 ($0)β–Ό Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (DH)

No recent open-market Form 4 cluster sales or emergency dumps flagged on DH. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP β€’ SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring DH)

  • βœ“Walkthrough of DH's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • βœ“3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • βœ“Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) β†’$100K Arena
DH // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +8.74%πŸ“ HORIZONTAL RANGE
2026-11-02O $1.14H $1.14L $1.12C $1.12VOL 335.8K
RES: $1.21SUP: $0.59SMA50: $0.99SMA200: $1.07
$2.71$2.14$1.57$1.00$0.43RES $1.21SUP $0.59$1.122026-05-042026-06-172026-08-042026-09-172026-11-02
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

DH Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

πŸ¦‹ DH Butterfly Map β†’ + Track DH β†’
Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth

vs. -4.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on DH today. View full Setup Ledger β†’

πŸ¦‹ Documented & Second-Order Butterfly Connections Open Graph β†’

No direct multi-tier Butterfly edges indexed yet for DH. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for DH today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk β†’
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT β€’ SEC EDGAR XBRL Γ— RQD PEER BENCHMARK

πŸ“Š Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (DH)

Technology Rank #384 of 714 βš”οΈ SWMR vs DH Full Matrix β†’

1. Head-to-Head Technology Peer Comparison (DH vs. SWMR, EGAN, HUCK, AEYE)

Industry: Computer Software: Prepackaged Software (222 Tracked Issuers)

Across 714 tracked Technology securities in the Roarable RQD universe, Definitive Healthcare Corp. (Class A) (DH) ranks #384 by composite RQD confidence (48/100, grade D) and #498 by equity capitalization ($162.4M). Within this direct 5-issuer industry benchmark cohort, EGAN leads on earnings valuation at 4.7x trailing P/E, while EGAN leads on capital efficiency and profitability with 46.7% ROIC and 70.1% gross margin. EGAN currently holds the highest overall quantitative score in the immediate peer group at 59/100 (C-) compared with DH at 48/100 (D).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
DH ACTIVE
Definitive Healthcare Corp. (Class A)
D 48/100 β€” 75.9% -35.0% 0.00% $162.4M Benchmark Subject
SWMR
Swarmer Inc
E 26/100 β€” 41.2% -35.0% -4.97% $167.4M /swmr-vs-dh β†’
EGAN
eGain Corporation
C- 59/100 4.7x 70.1% 46.7% -0.51% $150.1M /egan-vs-dh β†’
HUCK
Huckleberry.ai Inc. (Class B)
E 29/100 β€” 75.0% -35.0% +0.32% $147.7M /huck-vs-dh β†’
AEYE
AudioEye Inc.
D 46/100 β€” 78.3% -12.1% -7.72% $179.1M /aeye-vs-dh β†’

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K β€’ FILED 2025-12-31 β€’ CIK 0001861795

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Definitive Healthcare Corp. (Class A) (DH) reported GAAP revenue of $241.5M (-4.2% vs. FY2024 revenue of $252.2M , and -3.9% cumulative change since FY2023) , GAAP net income of -$138.9M, operating cash flow of $53.8M, and free cash flow of $37.1M (-19.2% YoY). On the balance sheet, DH closed FY2025 with $735.5M in total assets against $156.1M in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 7/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $241.5M -$138.9M $53.8M $37.1M $735.5M $156.1M
FY2024 (FY) 2024-12-31 $252.2M -$413.1M $58.2M $45.9M $1.09B $229.4M
FY2023 (FY) 2023-12-31 $251.4M -$202.4M $41.2M $41.2M β€” β€”

3. DH Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

βœ“ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is DH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-02, Definitive Healthcare Corp. (Class A) (NASDAQ: DH) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 48/100 at a spot price of $1.12 (0.00% 1D, market cap $162.4M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 12/20, and SEC Balance-Sheet Forensics 11/20. Across 714 tracked Technology issuers, DH ranks #384 in composite RQD confidence.

How does DH compare to SWMR and EGAN in the Technology sector?

Within the Technology sector (Computer Software: Prepackaged Software), DH carries a Roarable D (48/100 RQD), trailing P/E of N/A, gross margin of 75.9%, and ROIC of -35.0%. By comparison, SWMR (Swarmer Inc) holds a E grade (26/100 RQD, P/E N/A, ROIC -35.0%, cap $167.4M) and EGAN (eGain Corporation) posts a C- grade (59/100 RQD, P/E 4.7x, ROIC 46.7%, cap $150.1M). Among the 5-stock peer group, EGAN leads on earnings multiple (4.7x) while EGAN leads on capital efficiency (46.7% ROIC).

What are the biggest fundamental strengths and SEC risk factors for DH?

Per DH's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001861795), Definitive Healthcare Corp. (Class A) generated $241.5M in revenue (-4.2% YoY), -$138.9M in net income, and $37.1M in free cash flow against $735.5M in total assets and $156.1M in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity.. Primary risk factors monitored: Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is DH trading relative to its 50-day, 200-day, and 52-week technical levels?

DH last traded at $1.12 (0.00% on volume of 447,913 shares), positioning the stock +13.13% above its 50-day simple moving average ($0.99) and +4.67% above its 200-day simple moving average ($1.07). Across its 52-week range of $0.61 to $3.00, DH sits at the 21.3% percentile with a 14-day RSI of 63.9 (BULLISH MOMENTUM) and an implied next-earnings move of Β±10.8% ($1.00 to $1.24).

DH Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS β€’ SEC EDGAR Γ— CBOE Γ— FRED

Are DH insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies DH leadership and institutional positioning as: BALANCED INSTITUTIONAL POSITIONING.

Direct Sub-Reports: DH RQD Cockpit DH 12M Forecast DH Earnings & Move DH Dividends & DRIP DH Insiders & 13F DH Whale Options DH Profit Sankey DH News & Why
ROARABLE RATING BRIEF β€’ RQD 48/100 (D) βœ“ STAGE-C NUMBER FIREWALL VERIFIED

DH β€” Definitive Healthcare Corp. (Class A): What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:42:22Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, DH scores 48 out of 100, grade D, labeled "Roarable Sell β€” Underperform / Distribution Warning." The five pillars are:

  • Fundamental Cash Engine: 4 / 20. Per the RQD rating, ROIC is -35% and FCF yield is 22.82%. For a prospective investor, the weak ROIC indicates the company is not currently earning returns on invested capital, while the high FCF yield is a positive cash-generation signal that the rating weighs only lightly against the profitability deficit.
  • Whale 13F Flow: 11 / 20. The rating reflects institutional accumulation and options positioning at a moderate level. Holder-level detail is not available in source data, so the specific direction of institutional flows cannot be confirmed here.
  • Insider Conviction: 11 / 20. The rating reflects SEC Form 4 and Congressional PTR cluster flow at a moderate level. Individual transaction records are not available in source data.
  • Macro Regime Fit: 12 / 20. Per the RQD rating, beta is 1.0 and the score reflects sector sensitivity. A beta of 1.0 implies market-level sensitivity to broad moves, which means DH's price may track the overall market rather than offering defensive or differentiated behavior.
  • Forensic Balance Sheet: 10 / 20. Per the RQD rating, Altman Z is 0.2, Piotroski F is 7/9, and Debt/Equity is 0.41. The low Altman Z is a distress-zone signal, partly offset by a relatively strong Piotroski reading and moderate leverage.

Taken together, the rating points to a stock whose cash generation and balance sheet mix is the most mixed element, while profitability and distress metrics weigh heavily on the overall score. A prospective investor should treat the Roarable rating as an analytical framework that summarizes these tradeoffs, not as a recommendation to buy or sell.

Business

Definitive Healthcare Corp. (Class A) is a NASDAQ-listed issuer in the Technology sector, operating in the Computer Software: Prepackaged Software industry, per the company profile. The source data does not describe its specific products, customer base, or revenue model. Per the market data, gross margin is 75.9%, indicating a high-margin software revenue profile, though the source data does not confirm the underlying business mechanics.

Financial Trend

PeriodRevenueOperating IncomeNet IncomeEPSFCFCashDebt
FY 2025$241.5M$-224.3M$-138.9MN/A$37.1M$163.6M$156.1M
FY 2024$252.2M$-710.8M$-413.1MN/A$45.9M$105.4M$229.4M
FY 2023$251.4M$-329.8M$-202.4MN/A$41.2MN/AN/A

Per the SEC financials, revenue has been broadly flat across the three reported years, moving from $251.4M to $252.2M to $241.5M, while operating and net losses have been substantial in each period. Per the market data, operating margin is -60%, net margin is -57.5%, and ROIC is -35%. The RQD rating reports an Altman Z-Score of 0.2 and a Piotroski F-Score of 7/9, and a Debt/Equity ratio of 0.41. Reported cash rose from $105.4M in FY 2024 to $163.6M in FY 2025, while debt declined from $229.4M to $156.1M over the same period.

Recent Catalysts & News Wire Analysis

Per the recent news and catalysts section, the most recent items are largely market-wire and aggregator reports. One item is flagged as a CATALYST and concerns Simply Wall St coverage of Veeva Systems and IQVIA; this relates to a peer rather than to DH directly. A TradingView item cites a Q3'26 revenue estimate of 54.57M USD for DH. A Stock Titan item reports that a legal chief received 864,534 shares following tax withholding. The remaining items are generic market-activity and positioning summaries with no company-specific detail. Per the Butterfly Supply-Chain Graph, no supply-chain links or proprietary signals are recorded for DH.

Butterfly Effect: 2nd-Order Supply-Chain & Sector Ripples

Per the Butterfly Supply-Chain Graph, the supply chain is recorded as NONE, with no butterfly links and no proprietary signals. The source data therefore does not identify upstream suppliers, downstream customers, or sector correlations. Based strictly on the sector and industry classification, the peer references in the news wire (Veeva Systems and IQVIA) are the only related names mentioned, and the source data does not describe the nature of any dependency. A prospective investor should watch for any future disclosure of customer concentration or supplier dependency, though none is available in the current source data.

Open Questions

  • What are the company's specific products, customers, and revenue model, given that the source data describes only the sector and industry?
  • What drove the FY 2024 operating loss of $-710.8M, and what portion is non-recurring versus ongoing?
  • Why are FY 2025 and FY 2024 EPS values listed as N/A, and what is the share count underlying the $162.4M market capitalization?
  • What is the cash burn and liquidity runway, given Altman Z-Score of 0.2 and the reported cash and debt levels?
  • What does the $0.61 to $3 52-week range reflect in terms of company-specific events?

DH Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Definitive Healthcare Corp. (Class A) (DH) β€’ Click "Debate This Headline" to argue it in the Roar Pit below

πŸ’¬ Jump to DH Debate Forum (3) ↓
πŸ”₯ THE ROAR PIT β€’ LIVE COMMUNITY DEBATE 3 Active Posts & Replies

DH Bull vs. Bear Conversation Board β€” What's Your Call at $1.12?

πŸ‚ 50% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON DH 🐻 50% BEARISH CONVICTION
1. Pick Your Side on DH:
πŸ’‘ Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
RO RoarDesk_Moderator Roarable Research Desk βš–οΈ DEBATE HOST 🎯 Target: $1.21 (+8.0%)
πŸ“Œ Pinned Debate

πŸ”₯ Official Bull vs. Bear Debate: Is DH (D β€’ RQD 48/100) a Buy at $1.12?

Welcome to the DH (Definitive Healthcare Corp. (Class A)) Roar Pit. Current RQD Composite is 48/100 (Roarable Sell β€” Underperform / Distribution Warning) in Computer Software: Prepackaged Software. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (πŸ‚ Bull or 🐻 Bear) and drop your price target below.

SK SkepticalCFA Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $0.90 (-19.6%)
Spot @ $1.12

Pump the brakes on DH β€” check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on DH, but look at what you are paying: current EV/EBITDA multiples with 75.9% gross margins. Unless Definitive Healthcare Corp. (Class A) expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

MI MidwestValue Verified K Arena Trader πŸ‚ BULLISH 🎯 Target: $1.43 (+27.7%)
Spot @ $1.12

DH cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on DH, the market is fixating on short-term headline noise in Computer Software: Prepackaged Software and ignoring the balance sheet and cash flow trajectory. At $1.12 (52-wk range $0.61 - $3.00), any beat on forward guidance forces shorts and underweight funds to chase.

LIVE TAPE SPY $755.72 -0.38% QQQ $690.49 -1.44% DIA $517.13 -0.37% IWM $279.33 +0.96% NVDA $204.64 -4.22% AAPL $344.63 -1.23% MSFT $521.91 -1.55% TSLA $399.81 -0.86% PLTR $184.11 -6.27% SOFI $16.76 -4.83% IBIT $43.36 -0.94% GLD $355.78 -1.34%